VIDEO: Risk for NASH may increase with type 2 diabetes

BOSTON — In this exclusive video from The Liver Meeting 2019, Vlad Ratziu, MD, PhD, professor of hepatology at Sorbonne University and Pitié-Salpêtrière Hospital, discusses his poster presentation on the diagnostic aspects of nonalcoholic steatohepatitis in patients with type 2 diabetes.“The interest of this biomarker, called NIS4, is that it allows classification of patients in those that have severe disease and those that have mild or no disease,” Ratziu told Healio Gastroenterology and Liver Disease. “It’s important to do thisRead More

Share on facebook
Share on twitter
Share on linkedin